Trial
NCT04652765
Camostat With Bicalutamide for COVID-19
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Covid19
Intervention
Camostat Mesilate
Why stopped
PI Decision to close/stop the study due to no new accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-06